Clinical Trials For Parkinson’s Disease

Be part of the future of Parkinson’s treatment. By joining our various Parkinson’s clinical trials, you’ll gain access to potential new therapies, receive expert medical care, and contribute to groundbreaking research that could improve the lives of millions. Your participation plays a vital role in the search for better treatments – and possibly a cure.

Call to join our Parkinson’s clinical trials

"*" indicates required fields

Step 1 of 3

Submit your interest to our team of specialists

This field is hidden when viewing the form

Lead Source

First Name*

Last Name*

Email*

Phone Number*

What is Parkinson’s Disease?

Parkinson’s disease is a degenerative condition of the nervous system which affects approximately 145,000 adults in the UK. The disease is progressive and incurable with symptoms including involuntary tremors and shaking, muscular rigidity, difficulties with balance and slow, imprecise movement. Additional symptoms associated with Parkinson’s may also include sensations of feeling dizzy, lightheaded or faint.

Parkinson’s is caused by a loss of nerve cells in part of the brain, but it is not known what causes the nerve cells to die. Extensive research is currently underway in the field of Parkinson’s, not only to find the causes but also searching for new treatments for the symptoms and ultimately to find a cure. With every study undertaken, we understand more about the disease; research is always invaluable and results are always promising.

New Clinical Trials for Parkinson’s

We’re proud to be involved in international clinical trials for Parkinson’s focused on developing new medications to manage symptoms and slow disease progression. These final-phase studies include treatments for Parkinson’s-related neurogenic orthostatic hypotension (nOH), a condition that causes dizziness and sudden drops in blood pressure when standing.